Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01490346 · ClinicalTrials.gov registry record
Tissue Drug Levels of HIV Medications
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 22
- Enrollment target
NCT01490346 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 22 participants.
The verdict
NCT01490346 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The aim of this study is to find out why HIV continues to make copies in people taking HIV drugs. The investigators want to know if the medications most people use to treat HIV get into the lymphatic tissue where HIV persists.
Interventions
- DRUG Initiation of anti-retroviral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-09 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01490346
The ClinicalTrials.gov registry entry for NCT01490346 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Initiation of anti-retroviral therapy is the first listed.
NCT01490346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01490346 about?
NCT01490346 is a clinical study titled "Tissue Drug Levels of HIV Medications". The aim of this study is to find out why HIV continues to make copies in people taking HIV drugs. The investigators want to know if the medications most people use to treat HIV get into the lymphatic tissue where HIV persists.
What is the current status of trial NCT01490346?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2008-09. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01490346?
The interventions under investigation include: Initiation of anti-retroviral therapy (DRUG).
Who is sponsoring clinical trial NCT01490346?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.